Zacks Investment Research on MSN
Looking for a Fast-paced Momentum Stock at a Bargain? Consider Emergent Biosolutions (EBS)
Momentum investing is essentially an exception to the idea of "buying low and selling high." Investors following this style of investing are usually not interested in betting on cheap stocks and ...
9d
Investors in Emergent BioSolutions (NYSE:EBS) have unfortunately lost 90% over the last five years
Emergent BioSolutions Inc. ( NYSE:EBS ) shareholders will doubtless be very grateful to see the share price up 56% ...
Zacks Investment Research on MSN
Emergent Biosolutions (EBS) Beats Q3 Earnings and Revenue Estimates
Emergent Biosolutions (EBS) came out with quarterly earnings of $1.06 per share, beating the Zacks Consensus Estimate of a loss of $0.12 per share. This compares to earnings of $1.37 per share a year ...
GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Wednesday reported profit of $51.2 million in its third quarter. On a per-share basis, the Gaithersburg, ...
Emergent Biosolutions (EBS) is scheduled to announce Q3 earnings results on Wednesday, October 29th, after market close. The consensus EPS Estimate is $0.11 (-9 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback